Your weight loss journey
Average progress over time, across all newer medications.
Less hunger and food noise — your body is adjusting. Scale may not move yet.
For a 240 lb person, roughly 5–7 lbs.
Well into the active weight loss phase. Dose is ramping up.
Clothes fit differently. Health markers improving. For a 240 lb person, roughly 24–34 lbs.
Weight loss slows as your body reaches a new equilibrium.
Semaglutide injection ~15%, semaglutide pill ~17%, tirzepatide ~21%.
Ranges across newer drugs. Individual results vary by drug, dose, and person.
Results by drug
How quickly you lose depends on which drug you take. Average trial results at each milestone.
About 57% of people lost 20%+
With full adherence
About 37% of people lost 20%+
Daily pill, no food timing restrictions
Averages from studies at highest approved dose. For a 240 lb person. Not everyone achieves these results.
Want your personal numbers? Try the calculator
What the first weeks actually feel like
Week 1–2
Less hunger between meals. Food noise quiets. Some people feel nausea — usually mild and short-lived.
Week 3–4
Portions naturally shrink. Scale starts moving. You may eat half of what you used to without trying.
Month 2–3
Dose increases bring faster loss. Nausea usually settles. Clothes feel looser. Other people may start to notice.
Want the full week-by-week guide? Read: Your first weeks on medication
After peak results — what happens next?
Weight loss typically plateaus around months 12–15. This does not mean the drug stopped working. It means your body has reached a new equilibrium. The drug is still actively preventing regain.
If you continue
- Weight loss maintained long-term in trials
- Health improvements (blood pressure, blood sugar) preserved
- Ongoing cost — explore savings programs and insurance
If you stop
- About 2 in 3 people regain most weight within 1 year (semaglutide)
- Around 14% body weight regain within a year (tirzepatide)
- Hunger signals return — this is biology, not willpower
Current evidence suggests most people need to continue medication long-term. Research on lower maintenance doses is ongoing. This is a decision to revisit regularly with your doctor — not a one-time choice.
If you are not taking medication
This timeline is for medication. Lifestyle changes — diet and exercise — follow a similar shape, at a smaller scale. In clinical trials, participants following sustained dietary changes typically lost 5–10% of body weight, compared with 7–21% among those on GLP-1 medications. All dietary approaches produce similar results when calories are matched and adherence is sustained — the specific diet matters less than whether you can stick with it.
The Look AHEAD trial, an 8-year study of intensive lifestyle intervention, found the same front-loaded pattern: participants lost about 6% of body weight by year 1, settling to 4.7% by year 8. Progress is fastest early, then levels off — the same shape as the medication timeline above, just smaller in size.
This site does not rank diet against medication — they are not mutually exclusive. See Diet for the evidence behind specific approaches, and Lifestyle for how diet, exercise, and medication fit together.
Common questions
Written and maintained by one person · Built with agentic AI tools · Every number checked against the cited trial · Not medical advice
Timeline milestones are derived from the following clinical trials. All measured weight loss over 52–72 weeks versus placebo.
- SURMOUNT-1 (tirzepatide): 2,539 participants, 72 weeks. 20.9% average weight loss at 15mg dose.
- STEP 1 (semaglutide injection): 1,961 participants, 68 weeks. 14.9% average weight loss at 2.4mg dose.
- OASIS 4 (oral semaglutide): 667 participants, 68 weeks. 16.6% weight loss with full adherence.
- ATTAIN-1 (orforglipron): 3,127 participants, 72 weeks. 12.4% average weight loss at highest dose.
- STEP 4 (semaglutide continuation): Showed weight regain begins within weeks of stopping. Most returned to baseline by 2 years.
- SURMOUNT-4 (tirzepatide continuation): 14% body weight regain within 1 year of stopping.
- PMC 2024 — 47 RCTs, 3,363 participants: Compared alternate day fasting, continuous caloric restriction, and time-restricted eating. Sustained dietary changes produced 5–10% weight loss when people stuck with it.
- Look AHEAD trial — 5,145 participants, 8 years: Intensive lifestyle intervention produced 6% weight loss at year 1, settling to 4.7% at year 8.
See results by medication
Next step most people take
Built with agentic AI tools and not a substitute for medical advice
Last reviewed: